Detalles de la búsqueda
1.
Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug Reactions.
Cancer Treat Res
; 184: 75-85, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36449189
2.
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.
Oncologist
; 24(4): 537-548, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30842244
3.
Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).
EClinicalMedicine
; 31: 100693, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33554084
Resultados
1 -
3
de 3
1
Próxima >
>>